期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

单纯性肥胖和代谢综合征患者血浆内脂素水平变化及临床意义

下载PDF
导出
作者 康静 成蓓 戚本玲 杨彬
机构地区 华中科技大学同济医学院附属协和医院高干科
出处 《临床荟萃》 CAS 2010年第23期2071-2073,共3页 Clinical Focus
关键词 肥胖症 代谢综合征X 内脂素
分类号 R589.25 [医药卫生—内分泌]
  • 相关文献

参考文献11

  • 1宋秀霞 ,纪立农 .国际糖尿病联盟代谢综合征全球共识定义[J].中华糖尿病杂志（1006-6187）,2005,13(3):178-180. 被引量：610
  • 2Hanley AJ, Wagenknecht LE, d'Agostino RB Jr, et al. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome[J]. Diabetes, 2003,52 ( 11 ) : 2740-2747.
  • 3Meerarani P, Badimon J J, Zias E, et al. Metabolic syndrome and diabetic at herothrombosis: implications in vascular complications[J]. Curr Mol Med,2006,6(5) :501-514.
  • 4Diamantopoulos EJ,Andreadis EA,Tsourous GI,et al. Early vascular lesions in subjects with metabolic syndrome and prediabetes[J]. Int Angiol,2006,25(2) : 179- 183.
  • 5Klein Big., Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam[J]. Diabetes Care, 2002,25(10) : 1790-1794.
  • 6Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytok-ine visfatin in 3T3 1.1 adipoeytes[J]. Endocrinol, 2005,185 ( 3 ): R1-8.
  • 7Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat thai mimics the effects of insulm[J]. Science,2005,307(5708) :426-430.
  • 8Bemdt J, Kloting N, Kralisch S, et al. Plasma visfatin concentration and fat depot-specific mRNA expression in humans[J]. Diabetes, 2005,54(10) :2911 -2916.
  • 9Chen MP,Chung FM,Chang DM,et al. Elevated plasma level of visfalin/pre-B ceil colony-enhancing factor in patients with type 2 diabetes mellitus[J]. Clin Endocrinol Metab, 2006,91 (1):295 -299.
  • 10Sethi JK, VidaI-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? [J]. Trends Mol Med, 2005.11 (8) :344-347.

二级参考文献22

  • 1Nesto RW. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev Cardiovasc Med,2003,4(suppl 6):s11-s18.
  • 2Pouliot MC, Després JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol,1994,73:460-468.
  • 3Brunzell JD, Ayyobi AF. Dyslipidemia in the metabolic syndrome and type 2 diabetes mellitus. Am J Med,2003,115(suppl 8A):24s-28s.
  • 4Robins SJ, Rubins HB, Faas FH, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. The Veterans Affairs HDL Intervention Trial (VA-HIT). Diabetes Care,2003,26:1513-1517.
  • 5Steinmetz A, Fenselau S, Schrezenmeir J. Treatment of dyslipoproteinemia in the metabolic syndrome. Exp Clin Endocrinol Diabetes,2001,109:s548-559.
  • 6Robins SJ, Collins D, Wittes JT, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA, 2001,285:1585-1591.
  • 7Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care, 2004,27:1182-1186.
  • 8Lindstrom J, Louheranta A, Mannelin M. The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care, 2003,26:3230-3236.
  • 9Tuomilehto J, Lindstrm J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM, 2001,344:1343-1350.
  • 10Heart Protection Study Collaborative Group, MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet,2003,361:2005-2016.

共引文献609

临床荟萃
2010年 第23期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部